Abstract
Glycycoumarin (GCM) is a representative of coumarin compounds isolated from licorice, a popular herbal plant which is widely used to treat various diseases including liver diseases. This study was designed to evaluate the protective effects of GCM on hepatic steatosis in the setting of non-alcoholic fatty liver disease using both cell culture model of OA(oleic acid)/PA(palmitate acid)-induced lipids accumulation and a murine model of hepatic steatosis induced by a methionine-choline-deficient (MCD) diet. Results showed that GCM was highly effective in removing lipids droplets in both in vitro and in vivo models. Mechanistically, we demonstrated that activation of adenosine 5,-monophosphate (AMP)-activated protein kinase (AMPK)-mediated lipophagy, lipogenesis inhibition and enhanced fatty acid oxidation contributed to the anti-lipogenic effect of GCM. Our findings support a possible usefulness of GCM as a novel agent to mitigate hepatic steatosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
